Waldencast plc

NasdaqCM WALD

Waldencast plc Price to Book Ratio (P/B) on January 14, 2025: 0.61

Waldencast plc Price to Book Ratio (P/B) is 0.61 on January 14, 2025, a -68.16% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
  • Waldencast plc 52-week high Price to Book Ratio (P/B) is 1.97 on January 17, 2024, which is 225.24% above the current Price to Book Ratio (P/B).
  • Waldencast plc 52-week low Price to Book Ratio (P/B) is 0.57 on August 12, 2024, which is -6.40% below the current Price to Book Ratio (P/B).
  • Waldencast plc average Price to Book Ratio (P/B) for the last 52 weeks is 0.99.
Key data
Date Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield Price to Earnings Ratio (P/E)
Market news
Loading...
NasdaqCM: WALD

Waldencast plc

CEO Mr. Michel Brousset
IPO Date May 12, 2021
Location United States
Headquarters 10 Bank Street
Employees 284
Sector Consumer Discretionary
Industries
Description

Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.

Similar companies

VERX

Vertex, Inc.

USD 52.91

0.92%

VTEX

VTEX

USD 5.95

2.23%

WFCF

Where Food Comes From, Inc.

USD 12.69

0.08%

StockViz Staff

January 15, 2025

Any question? Send us an email